Connect with us

Business

Africa Health Excon: Positioning Africa as the continental hub for health innovation and trade

Published

on

Merck

Merck is actively bringing technical and process expertise with various key African countries and customers to build local manufacturing capabilities

CAIRO, Egypt, June 6, 2022/APO Group/ — 

The Merck (MerckGroup.comAfrica Bureau aims to accelerate the business transformation of the company operations in Africa to ensure sustainable business and create long-term value. Merck has unveiled plans to expand its footprint in Africa through a four-tiered program of awareness, diagnosis, training of healthcare professionals, and treatment access. Merck announced the brand-new Thyroid awareness program: ThyroAfrica to spread disease awareness. Africa Cancer Care program will be launched to enhance colorectal cancer diagnosis across Africa. Merck continues its work in the fight against Malaria and the neglected tropical disease (NTD) schistosomiasis. Merck is actively bringing technical and process expertise with various key African countries and customers to build local manufacturing capabilities.

Merck, a leading science and technology company, announced today its further commitment to Africa, by strategically expanding its access and awareness programs and strengthening the health systems and patients in low- and middle-income countries across the continent. The announcement came today during the Africa Health ExCon from 5th to 7th of June 2022 in Cairo, Egypt.

In this three-day event, stakeholders across Africa are meeting to learn from the worldwide leaders and experts in healthcare, as well as to share and exchange knowledge and experiences with more than 20,000 participants from more than 55 countries. The key objectives of Africa Health ExCon are refocusing on Africa’s investment potential, ensuring equitable access of health technology, the thriving of the health and pharma businesses, and incubating health innovation and trade in Africa.

”Our aspiration is to be one of the leading healthcare partners in sub-Saharan Africa and to work with NGOs and governments to build and strengthen sustainable health systems within it,” said Dr. Karim Bendhaou, Head of Merck Africa Bureau. “The Merck Africa Bureau aims to accelerate the business transformation of our operations in Africa to ensure sustainable business and create long-term value while seeking to balance environmental, social, and governance aspects. Through the four pillars of Private Public Partnership model, we work hand in hand with our stakeholders through various programs to fight counterfeit medicines, to invest in the technology transfer, to support supply chain sustainability and localization, and to decrease fragmentation of the market.’’

During the ExCon, Merck has unveiled plans to expand its footprint in Africa through a four-tiered program of awareness, diagnosis, training of healthcare professionals and treatment access. The company announced their brand-new Thyroid awareness program and upcoming launch of the Africa Cancer Care program in addition to enhancing ongoing initiatives.

Thyroid disease awareness is relatively very low in Africa. The ThyroAfrica program’s objective is to establish a collaborative partnership with the endocrinology & thyroid disease societies in Africa. This aims to increase disease awareness via communication channels for mass reach of around 7 million people and to offer the proper link for TSH (thyroid-stimulating hormone) test.

Merck has unveiled plans to expand its footprint in Africa through a four-tiered program of awareness, diagnosis, training of healthcare professionals, and treatment access

Africa Cancer Care program will be launched by the end of June to enhance colorectal cancer diagnosis across Africa by creating hubs of RAS testing in African countries such as Kenya and Nigeria. The RAS (RAT Sarcoma) test is a gene mutation analysis in colorectal cancer. As a predictive biomarker for the disease, it helps to guide treatment and determine outcomes. This would help to counteract the rising demand for specialist care especially with the existing healthcare facilities that require the scaling of resources. This has led to the rise in medical tourism across the continent, as individuals seek specialised care elsewhere. This is in addition to enhancing access to medication and providing HCP capacity-building programs through high quality trainings to oncologists, pathologists, nurses to support diagnosis and treatment of metastatic colorectal cancer in Africa.

“We will remain fully committed to increase access to innovative medicines across Africa and on ground awareness campaigns in a favour of underserved populations in low- and middle-income countries in Africa through our investments and our innovations in science & technology, together with our external partners,” said Ramsey Morad, Regional Vice-President, Head Middle East, Africa, Turkey & Russia/CIS at Merck Healthcare. “Beyond developing novel treatments, we must address the gaps in awareness, accessibility, affordability and availability of treatment.’’

After having signed a Memorandum of Understanding, Merck and the African Federation for Fertility Societies (AFFS) have been jointly working on an agenda to further develop educational training programs for healthcare professionals, aimed at improving access to high-quality infertility care for patients in Africa. By combining their forces, AFFS has sought support from Merck in order to develop a regional patient awareness campaign to be launched later this year. Additionally, they are hosting a multi-national advisory board to gain insights on educational gaps for healthcare professionals in AFFS member societies in African countries.

Professor Gamal Serour, President of African Federation of Fertility Societies stated that “AFFS welcomes and appreciates collaboration with Merck for the implementation of high-quality care across Africa”.

Merck also continues its work in the fight towards the elimination of the neglected tropical disease (NTD) schistosomiasis towards its elimination as a public health burden. In partnership with the World Health Organization (WHO), we provide up to 250 million tablets of praziquantel per year to treat mainly school-aged children in sub-Saharan Africa (SSA).  Since 2007, Merck has donated over 1.5 billion tablets and enabled the treatment of more than 600 million school-aged children in 47 countries in SSA. To support the elimination of schistosomiasis, Merck have adopted an integrated approach which, beyond medicines, includes health education as well as water, sanitation and hygiene (WASH) initiatives. We also conduct research for new drugs and diagnostics and develop, together with a consortium of partners, a potential new paediatric treatment option for children as of 6 years of age and below.

Since 2015, Merck has also been very active in the fight against malaria through a holistic approach to prevent, control, and eliminate the disease. Examples include our M5717 drug development program as well as the creation of the Pan African Vivax and Ovale Network (PAVON) in over 10 countries, which has led to important policy changes regarding malaria in Botswana.

During the ExCon, Merck aims to strengthen our existing cooperation with the Pharma industry and Medicine & Quality Regulators across the continent in addition to highlighting strategic projects in Africa carried out by Merck’s Life Science business sector. These efforts bring our expertise in touch with various key African countries and research institutes to enable distributed manufacturing of much-needed vaccines, biological drugs, and therapies in African countries. “Our goal at Merck is to support capacity-building of biologics manufacturing and development in Africa,” said Youssef Gaabouri, Head of Sales Middle East & Africa at Merck Life Science BioProcessing. Furthermore, Merck provides expertise to Regulatory Agencies and shares knowledge regarding the use of quality products for audit purposes. In line with the Merck’s commitment to sustainable access to health solutions in low- and middle-income countries, we implement and enhance health access programs through our shared value initiatives, global health partnerships, and access to medicine strategy.

Distributed by APO Group on behalf of Merck.

Business

Created to explore: Canon EOS R8 Mark II inspires full-frame confidence and stability in a travel-ready size

Published

on

The Canon EOS R8 Mark II combines portability with full-frame mirrorless camera quality and advanced stabilisation to capture wider views, beautiful background blur and stunning low-light image quality

DUBAI, United Arab Emirates, September 17, 2026/APO Group/ –Canon today unveils the Canon EOS R8 Mark II (https://apo-opa.co/4j8ZE9t), a lightweight full-frame camera that inspires confidence and offers creative freedom.

The Canon EOS R8 Mark II combines portability with full-frame mirrorless camera quality and advanced stabilisation to capture wider views, beautiful background blur and stunning low-light image quality.

 




 
 

Building on the success of the EOS R8, the Canon EOS R8 Mark II responds to the needs of photographers with greater control and capability in a compact body. Made for those who want to explore more, from new places to new creative ideas, the Canon EOS R8 Mark II is a versatile choice for travel photography. It’s easy to carry, simple to use and helps to capture unrepeatable moments.

The distinctly modern design marks a new chapter in the EOS R System. The Canon EOS R8 Mark II carries forward Canon’s design heritage while evolving it into a more contemporary form that meets the needs and preferences of today’s photographers and creators.

At the heart of the Canon EOS R8 Mark II is a 24.2MP full-frame CMOS sensor, complemented by a DIGIC X processor. Together, they deliver exceptional clarity, rich colour and impressive dynamic range. A powerful In-Body Image Stabilizer (IBIS) provides up to 7.5 stops1 of stability, making it easier to shoot handheld and capture sharp images in low light and on the move without compromising image quality.

With an abundance of creative and performance-focused imaging technology in a compact, stabilised body, the Canon EOS R8 Mark II is well suited to travel photography. Its feature-rich design includes advanced capabilities inherited from high-end EOS R System cameras, such as Register People Priority, which automatically keeps selected individuals in focus, and pre-continuous shooting, which helps capture scenes that unfold in an instant, before the user has time to react.

Ready for every moment of the journey

From spotting wildlife on safari to street performers launching into spectacular tricks and festival crowds throwing colourful powder into the air, the most memorable travel experiences are often fleeting and difficult to photograph. With its 40fps2 shooting speed and expanded buffer that can handle up to 73 RAW files in a single burst, the Canon EOS R8 Mark II keeps pace with fast-moving action.

Pre-continuous shooting in H+ mode gives Canon EOS R8 Mark II users the edge during even more unpredictable situations. Recording approximately half a second before the shutter button is fully pressed, it provides up to 20 extra images to help secure the decisive shot. Whether you’re waiting for a crowd to clear at an iconic landmark or anticipating a family member’s reaction to trying a new cuisine, the Canon EOS R8 Mark II captures the shot before your reflexes do.

Dual Pixel CMOS AF II with Deep Learning subject detection automatically recognises and tracks people, animals and vehicles, bringing subjects into sharp focus rapidly with eye, face, head and body tracking. The Canon EOS R8 Mark II’s improved tracking persistence reliably maintains focus even when the subject briefly disappears from view, making it easy to keep travel companions in focus as they move through crowded locations. Autofocus is also possible in light levels as low as EV -7.53 – the same as the flagship EOS R1 professional camera.

Register People Priority brings additional precision when photographing the people who matter most. Users can register up to 10 faces in the camera and up to 100 on a memory card, allowing the Canon EOS R8 Mark II to automatically recognise registered family members and friends whenever they appear in the frame. It then focuses on them according to the priority set by the user – helping to keep loved ones sharp in busy travel scenes, group shots and spontaneous encounters.

Compact, lightweight, creative

A new streamlined EOS design offers confident, intuitive handling, with customisable buttons, controls and modes enabling users to personalise the Canon EOS R8 Mark II to suit their shooting style. The camera also pairs well with a versatile range of lightweight Canon RF lenses, from the all-purpose RF 24-105mm F4-7.1 IS STM (https://apo-opa.co/4xPaLIB) and ultra-fast RF 45mm F1.2 STM (https://apo-opa.co/4xWaF2r) prime to the compact RF 100-400mm F5.6-8 IS USM (https://apo-opa.co/4hcaau3) telephoto zoom for wildlife and distant subjects.

Design improvements compared with the EOS R8 include a multi-controller that makes it quicker to operate the camera when shooting handheld. The optional Canon Extension Grip EG-E2 further enhances handling, and features a separate tripod socket plus direct access to the camera battery for added convenience.

Flexible colour tools, including Canon Picture Styles and Filmtone Colour Filters, give photographers the freedom to capture the character of a destination as they experience it – and create images that make the viewer feel as though they are actually there. Additionally, the Canon EOS R8 Mark II’s adjustable, natural-looking Smooth Skin effect makes it easy to create flattering portraits straight from the camera without the need for complex post-processing.

Photographers can also explore the world of immersive three-dimensional images and models. The Canon EOS R8 Mark II is the first camera to include Canon’s new Dual Pixel 3D imaging technology, allowing users to capture JPEGs containing depth information and convert them into 3D content using the free Dual Pixel 3D Converter App for Windows.4

The freedom to stay connected

Comprehensive connectivity means Canon EOS R8 Mark II users can share on the go. Wi-Fi® (2.4GHz / 5GHz)5 and Bluetooth® 5.3 provide fast and reliable wireless transfer of images and video, while support for the Canon Camera Connect app enables remote shooting and seamless image sharing from a smartphone. Automatic backups and image sorting via www.image.canon offer peace of mind while travelling.

A high-speed USB-C® port provides up to 10Gbps data transfer, along with USB charging and power delivery, giving users the flexibility to connect via cable when needed. For long days out, the ability to charge on the go and shoot for longer using a power bank adds further convenience. USB livestreaming also highlights the Canon EOS R8 Mark II’s versatility, making it simple to share adventures live while offering the freedom to explore new ways of using the camera over time.

High-quality video and sound recording make the Canon EOS R8 Mark II an ideal hybrid camera for those looking to explore their creativity in new ways. Oversampled 4K video from 6K delivers superior detail, while Full HD shot at up to 180fps opens up the world of slow-motion recording. Cinema View (2.35:1 aspect ratio) and Custom Picture profiles, including Canon Log 3 and HLG, make it simple to achieve a cinematic look, while Movie Digital IS helps maintain stable footage while filming handheld.

The Canon EOS R8 Mark II will appeal to photographers who value the creative possibilities of a full-frame sensor, but don’t want to compromise on portability. Bringing together image quality, speed and creative control in a travel-ready design, it’s a camera that’s ready for every journey.

Key features of the Canon EOS R8 Mark II:

• Lightweight at approximately 499g (546g with card and battery)

• 24.2MP full-frame sensor

• Up to 7.5-stop1 Coordinated lens and in-body IS

• 40fps2 continuous shooting,  with a bigger buffer than the EOS R8

• Pre-continuous shooting in H+ mode up to 20 frames

• Dual Pixel CMOS AF II with intelligent subject detection

• Filmtone Colour Filters, Custom Picture and Look File (LUT) support

• Wi-Fi® (2.4GHz / 5GHz)5 and Bluetooth® 5.3

• USB-C® connectivity and charging

• Livestreaming options

• Up to 4K 60p video, oversampled from 6K

Distributed by APO Group on behalf of Canon Middle East.

 

 




 

Continue Reading

Business

Load shedding has eased: South Africa now faces its next industrial energy test

Published

on

The EIUG Conference will bring together industrial energy users, policymakers, utilities, financiers and technology providers to examine what South Africa’s next phase of the energy transition means for the businesses that power its economy

JOHANNESBURG, South Africa, September 17, 2026/APO Group/ –South Africa’s energy conversation is changing. With Eskom recording more than 400 consecutive days without load shedding, the focus for energy-intensive businesses is shifting from simply securing electricity to ensuring that energy supports industrial competitiveness, investment and growth.

 




 
 

For South Africa’s mines, manufacturers, smelters and other large power users, significant challenges remain. Grid capacity, rising operating costs, renewable energy integration, power quality and the financing of alternative energy solutions are increasingly influencing investment and operational decisions.

These issues will take centre stage at the EIUG Conference, taking place 28–29 October 2026 at The Maslow Hotel, Sandton, Johannesburg, focused on the challenges and opportunities facing South Africa’s energy-intensive users.

The next industrial energy challenge

Large energy users are already changing how they source power. Seriti Green’s 155 MW Ummbila Emoyeni wind farm, which began commercial operations in July 2026, is supplying Seriti’s mining operations through wheeling, illustrating how industrial users are increasingly combining grid electricity with private renewable generation.

At the same time, transmission capacity is becoming critical as more generation connects to the system. Recent collaboration between the Development Bank of Southern Africa and National Transmission Company South Africa is aimed at accelerating investment in South Africa’s transmission network.

The EIUG Conference programme reflects these changing priorities.

The session “Industrialisation Under Threat?” will examine whether current energy and market conditions are supporting or constraining South Africa’s mining, manufacturing and smelting sectors, including the impact of energy costs, self-generation and changing industrial demand.

A dedicated Grid Security discussion will explore ageing infrastructure, renewable penetration, frequency stability, voltage fluctuations and the roles of NTCSA, Eskom, municipalities and industry in maintaining a reliable electricity system.

Delegates will also explore renewable energy integration for heavy industry, including how solar, wind and hybrid energy systems can support the continuous power requirements of mining, manufacturing, metals and cement operations.

Financing these changes will be equally important. The programme’s Finance for Transition Masterclass will cover financing models, de-risking, storage economics and investment in industrial decarbonisation projects.

From energy security to competitiveness

South Africa’s improved electricity availability is an important milestone, but the next measure of success will be whether the country can turn a changing energy system into stronger industrial growth.

The EIUG Conference will bring together industrial energy users, policymakers, utilities, financiers and technology providers to examine what South Africa’s next phase of the energy transition means for the businesses that power its economy.

The question is no longer only whether South Africa can keep the lights on, but whether its energy system can keep its industries competitive.

Event details

EIUG Conference 2026
28–29 October 2026
The Maslow Hotel, Sandton, Johannesburg

Distributed by APO Group on behalf of VUKA Group.

 

 




 

Continue Reading

Business

Afreximbank extends US$10-million facility to Azania Bank to support Small and Medium-sized Enterprises (SMEs) in Tanzania

Published

on

Delivered under Afreximbank’s Export SME Development Programme (ESDP), the facility will enable Azania Bank to provide eligible SMEs with both working capital and medium-term financing to support business expansion, asset acquisition and pre- and post-export operations

DAR ES SALAAM, Tanzania, September 17, 2026/APO Group/ –African Export-Import Bank (Afreximbank) (www.Afreximbank.com) has extended a US$10-million finance facility to Azania Bank of Tanzania (Azania Bank) to improve access to finance for Small and Medium-sized Enterprises (SMEs) across Tanzania’s export value chains and to strengthen their participation in regional and international trade

 




  

Delivered under Afreximbank’s Export SME Development Programme (ESDP), the facility will enable Azania Bank to provide eligible SMEs with both working capital and medium-term financing to support business expansion, asset acquisition and pre- and post-export operations. This is expected to boost productivity and enhance participation in regional and global value chains, while addressing persistent financing gaps that constrain SME growth and export development.

Azania Bank will on-lend the funds to eligible SMEs engaged in export-oriented activities across key sectors, including agriculture, manufacturing, trade, technology, logistics and value-added exports. The facility will enhance the bank’s ability to support the growing financing needs of SMEs and emerging businesses that play a vital role in Tanzania’s industrialisation and trade agenda.

The initiative is expected to support business growth, create employment opportunities, improve export readiness and strengthen Tanzania’s participation in regional value chains. It will also help SMEs leverage opportunities arising from the African Continental Free Trade Area (AfCFTA) by enhancing their capacity to participate effectively in cross-border trade and regional supply networks.

SMEs are the backbone of Africa’s productive economy and are critical to driving industrialisation

In addition to financing, Afreximbank will provide participating SMEs with structured business development support, including export readiness training, financial management advisory services, market linkage opportunities, digitalisation support and access to SME-focused knowledge and networking platforms. These interventions are designed to strengthen enterprise resilience, improve competitiveness and enable SMEs to scale sustainably.

Mrs. Oluranti Doherty, Managing Director, Export Development, Afreximbank commented: “SMEs are the backbone of Africa’s productive economy and are critical to driving industrialisation, value addition and trade-led growth. However, many businesses continue to face significant barriers to accessing the financing, market opportunities and technical support needed to scale and compete effectively”.

 

“Through the Export SME Development Programme, Afreximbank is partnering with financial institutions such as Azania Bank to provide not only financing, but also the capacity building and market access solutions required for SMEs to grow, export and integrate into regional and global value chains. We believe this partnership will contribute meaningfully to Tanzania’s export development objectives and help unlock new opportunities for local enterprises under the AfCFTA.”

Mr. Yahaya Mbanka, Director, Business Development, Azania Bank Plc, said: “This facility will strengthen our ability to provide Tanzanian SMEs with the financing they need to grow their businesses, invest in productive capacity and pursue export opportunities. Our partnership with Afreximbank will also enable us to offer support that responds more closely to the needs of businesses operating across Tanzania’s key value chains.”

The facility which supports Afreximbank’s mandate to promote trade, industrialisation and export development across Africa, also aligns with Tanzania’s priorities around domestic production, value addition, export diversification and regional trade integration.

Afreximbank’s 2025 Afreximbank Annual Trade Development Effectiveness Report (https://apo-opa.co/4hgL25z) (ATDER) shows that the Bank extended over US$960 million to more than 58,000 SMEs across Africa. The initiative which prioritized women- and youth-led enterprises among others, delivered trade finance facilities that empowered businesses to obtain the capital necessary to scale, engage in cross-border trade, and expand into new markets.

Distributed by APO Group on behalf of Afreximbank.

 

 




 

Continue Reading

Trending

Exit mobile version